WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Etrasimod is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.

There is limited information regarding Etrasimod FDA-Labeled Indications and Dosage (Adult) in the drug label.

There is limited information regarding Etrasimod FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

There is limited information regarding Etrasimod Contraindications in the drug label.

There is limited information regarding Etrasimod Warnings’ in the drug label.

There is limited information regarding Etrasimod Clinical Trials Experience in the drug label.

There is limited information regarding Etrasimod Postmarketing Experience in the drug label.

There is limited information regarding Etrasimod Drug Interactions in the drug label.

Pregnancy Category (FDA): There is no FDA guidance on usage of Etrasimod in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Etrasimod in women who are pregnant.

There is no FDA guidance on use of Etrasimod during labor and delivery.

There is no FDA guidance on the use of Etrasimod in women who are nursing.

There is no FDA guidance on the use of Etrasimod in pediatric settings.

There is no FDA guidance on the use of Etrasimod in geriatric settings.

There is no FDA guidance on the use of Etrasimod with respect to specific gender populations.

There is no FDA guidance on the use of Etrasimod with respect to specific racial populations.

There is no FDA guidance on the use of Etrasimod in patients with renal impairment.

There is no FDA guidance on the use of Etrasimod in patients with hepatic impairment.

There is no FDA guidance on the use of Etrasimod in women of reproductive potentials and males.

There is no FDA guidance one the use of Etrasimod in patients who are immunocompromised.

There is limited information regarding Etrasimod Administration in the drug label.

There is limited information regarding Etrasimod Monitoring in the drug label.

There is limited information regarding the compatibility of Etrasimod and IV administrations.

There is limited information regarding Etrasimod overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

There is limited information regarding Etrasimod Pharmacology in the drug label.

There is limited information regarding Etrasimod Mechanism of Action in the drug label.

There is limited information regarding Etrasimod Structure in the drug label.

There is limited information regarding Etrasimod Pharmacodynamics in the drug label.

There is limited information regarding Etrasimod Pharmacokinetics in the drug label.

There is limited information regarding Etrasimod Nonclinical Toxicology in the drug label.

There is limited information regarding Etrasimod Clinical Studies in the drug label.

There is limited information regarding Etrasimod How Supplied in the drug label.

There is limited information regarding Etrasimod Storage in the drug label.

There is limited information regarding Etrasimod Patient Counseling Information in the drug label.

Alcohol-Etrasimod interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

There is limited information regarding Etrasimod Brand Names in the drug label.

There is limited information regarding Etrasimod Look-Alike Drug Names in the drug label.

The contents of this FDA label are provided by the National Library of Medicine.